IRRAS — Irras AB Share News
0.000.00%
Last trade - 00:00- SEK127.49m
- SEK114.49m
- SEK40.00m
Brief: IRRAS: Expansion Of IRRAflow Launch To The Netherlands
Brief: Irras Awarded Breakthrough Technology Purchasing Agreement
Brief: Irras Q3 Loss Narrows To SEK 31.0 Million
Brief: Irras Announces Key IRRAflow Commercial Milestones In Germany
Brief: IRRAS Announces Release Of Clinical Data Regarding IRRAflow
Brief: Irras Q2 EBIT Loss Narrows To SEK 31.2 Mln
Brief: Irras Q2 Net Sales At SEK 1.2 Million
Brief: IRRAS Says Anders P. Wiklund, Chairman Of The Board Of Directors Of Co, Has Passed Away
Brief: IRRAS: Extension Of CE Mark For IRRAflow System Until May 2024
Brief: IRRAS: COVID-19 Delays Short-term Revenue
Brief: Irras Approved For Listing On Nasdaq Stockholm
Brief: Irras Q1 EBIT Loss Narrows To SEK 35.2 Mln
Brief: Irras AB To List On Nasdaq Stockholm
Brief: Irras Gets Approval For Loan From US Stimulus Package
Brief: IRRAS Announces Outcome Of Fully Guaranteed Rights Issue Of 217 MSEK
Brief: University of Helsinki, Neurosurgery Leader and IRRAS To Collaborate to Advance Uses of IRRAflow
Brief: Irras Resolves On Fully Underwritten Rights Issue Of SEK 217 Mln
Brief: Irras Q4 EBIT Loss Narrows To SEK 35.7 Million
Brief: IRRAS: US Launch Update, Product Portfolio Progress And Objectives For 2020